Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location
Authors:
- F ZijlstraFZF Zijlstra
- A W J van ’T HofAHA W J van ’T Hof
- M-J de BoerMBM-J de Boer
- J-H E DambrinkJDJ-H E Dambrink
- A T M GosselinkAGA T M Gosselink
- J C A HoorntjeJHJ C A Hoorntje
- J P OttervangerJOJ P Ottervanger
- H SuryapranataHSH Suryapranata
Open Access
Abstract
Objectives: To study the clinical significance of infarct location during long term follow up in a trial comparing thrombolysis with primary angioplasty. Design: Retrospective longitudinal cohort analysis of prospectively entered data. Setting: Patients with acute ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). Patients: In the Zwolle trial 395 patients with acute STEMI were randomly assigned to intravenous streptokinase or PCI. Main outcome measures: Survival according to infarct location and treatment after 8 (2) years of follow up. Results: 105 patients died: 63 patients in the streptokinase group and 42 patients in the primary PCI group (relative risk (RR) 1.6, 95% confidence interval (CI) 1.0 to 2.6; p = 0.03). In patients with non-anterior STEMI there was no difference in mortality between streptokinase and PCI treated patients (RR 1.1, 95% CI 0.6 to 2.1; p = 0.68) but the streptokinase group had significantly more major adverse cardiac events (MACE) than the PCI group (RR 2.1, 95% CI 1.2 to 3.6). The number needed to treat to prevent one MACE was four. In patients with anterior STEMI, mortality was higher in the streptokinase group than in the PCI group (RR 2.7, 95% CI 1.4 to 5.5; p = 0.004). The number needed to treat to prevent one death was five. Kaplan-Meier analysis confirmed the benefits of primary angioplasty in the first year and showed additional benefit of PCI compared with streptokinase between 1–8 years after the acute event. Conclusions: Patients with anterior STEMI have better long term survival when treated with PCI than with streptokinase. In patients alive one year after the acute event, PCI confers a significant additional survival benefit, probably due to better preserved residual left ventricular function.Keywords
This publication has 21 references indexed in Scilit:
- Angioplasty vs thrombolysis for acute myocardial infarction: a quantitative overview of the effects of interhospital transportationEuropean Heart Journal, 2003
- Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction Final results of the randomized national multicentre trial—PRAGUE-2European Heart Journal, 2003
- Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trialsThe Lancet, 2003
- Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial InfarctionNew England Journal of Medicine, 2002
- Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarctionEuropean Heart Journal, 2001
- Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE StudyEuropean Heart Journal, 2000
- Achieving tissue-level perfusion in the setting of acute myocardial infarctionThe American Journal of Cardiology, 2000
- Predictors of death and reinfarction at 30 days after primary angioplasty: The GUSTO Ilb and RAPPORT trialsAmerican Heart Journal, 2000
- Clinical and Angiographic Follow-Up After Primary Stenting in Acute Myocardial InfarctionCirculation, 1999
- Effect of Glycoprotein IIb/IIIa Receptor Blockade on Recovery of Coronary Flow and Left Ventricular Function After the Placement of Coronary-Artery Stents in Acute Myocardial InfarctionCirculation, 1998